Your browser doesn't support javascript.
loading
Colonisation of hospital surfaces from low- and middle-income countries by extended spectrum ß-lactamase- and carbapenemase-producing bacteria.
Nieto-Rosado, Maria; Sands, Kirsty; Portal, Edward A R; Thomson, Kathryn M; Carvalho, Maria J; Mathias, Jordan; Milton, Rebecca; Dyer, Calie; Akpulu, Chinenye; Boostrom, Ian; Hogan, Patrick; Saif, Habiba; Sanches Ferreira, Ana D; Hender, Thomas; Portal, Barbra; Andrews, Robert; Watkins, W John; Zahra, Rabaab; Shirazi, Haider; Muhammad, Adil; Ullah, Syed Najeeb; Jan, Muhammad Hilal; Akif, Shermeen; Iregbu, Kenneth C; Modibbo, Fatima; Uwaezuoke, Stella; Audu, Lamidi; Edwin, Chinago P; Yusuf, Ashiru H; Adeleye, Adeola; Mukkadas, Aisha S; Mazarati, Jean Baptiste; Rucogoza, Aniceth; Gaju, Lucie; Mehtar, Shaheen; Bulabula, Andrew N H; Whitelaw, Andrew; Roberts, Lauren; Chan, Grace; Bekele, Delayehu; Solomon, Semaria; Abayneh, Mahlet; Metaferia, Gesit; Walsh, Timothy R.
Afiliação
  • Nieto-Rosado M; Department of Biology, Ineos Oxford Institute for Antimicrobial Research, University of Oxford, Oxford, UK. maria.nietorosado@biology.ox.ac.uk.
  • Sands K; Division of Infection and Immunity, Cardiff University, Cardiff, UK. maria.nietorosado@biology.ox.ac.uk.
  • Portal EAR; Department of Biology, Ineos Oxford Institute for Antimicrobial Research, University of Oxford, Oxford, UK.
  • Thomson KM; Division of Infection and Immunity, Cardiff University, Cardiff, UK.
  • Carvalho MJ; Department of Biology, Ineos Oxford Institute for Antimicrobial Research, University of Oxford, Oxford, UK.
  • Mathias J; Division of Infection and Immunity, Cardiff University, Cardiff, UK.
  • Milton R; Department of Biology, Ineos Oxford Institute for Antimicrobial Research, University of Oxford, Oxford, UK.
  • Dyer C; Division of Infection and Immunity, Cardiff University, Cardiff, UK.
  • Akpulu C; Division of Infection and Immunity, Cardiff University, Cardiff, UK.
  • Boostrom I; Department of Medical Sciences, Institute of Biomedicine, University of Aveiro, Aveiro, Portugal.
  • Hogan P; Division of Infection and Immunity, Cardiff University, Cardiff, UK.
  • Saif H; Division of Infection and Immunity, Cardiff University, Cardiff, UK.
  • Sanches Ferreira AD; Centre for Trials Research, Cardiff University, Cardiff, UK.
  • Hender T; Division of Infection and Immunity, Cardiff University, Cardiff, UK.
  • Portal B; Centre for Trials Research, Cardiff University, Cardiff, UK.
  • Andrews R; Department of Biology, Ineos Oxford Institute for Antimicrobial Research, University of Oxford, Oxford, UK.
  • Watkins WJ; Division of Infection and Immunity, Cardiff University, Cardiff, UK.
  • Zahra R; Division of Infection and Immunity, Cardiff University, Cardiff, UK.
  • Shirazi H; Division of Infection and Immunity, Cardiff University, Cardiff, UK.
  • Muhammad A; Division of Infection and Immunity, Cardiff University, Cardiff, UK.
  • Ullah SN; Division of Infection and Immunity, Cardiff University, Cardiff, UK.
  • Jan MH; Parasites and Microbes Programme, Wellcome Sanger Institute Hinxton, Hinxton, UK.
  • Akif S; Division of Infection and Immunity, Cardiff University, Cardiff, UK.
  • Iregbu KC; Division of Infection and Immunity, Cardiff University, Cardiff, UK.
  • Modibbo F; Division of Infection and Immunity, Cardiff University, Cardiff, UK.
  • Uwaezuoke S; Division of Infection and Immunity, Cardiff University, Cardiff, UK.
  • Audu L; Department of Microbiology, Quaid-i-Azam University, Islamabad, Pakistan.
  • Edwin CP; Pakistan Institute of Medical Sciences, Islamabad, Pakistan.
  • Yusuf AH; Department of Microbiology, Quaid-i-Azam University, Islamabad, Pakistan.
  • Adeleye A; Department of Microbiology, Quaid-i-Azam University, Islamabad, Pakistan.
  • Mukkadas AS; Department of Microbiology, Quaid-i-Azam University, Islamabad, Pakistan.
  • Mazarati JB; Department of Microbiology, Quaid-i-Azam University, Islamabad, Pakistan.
  • Rucogoza A; National Hospital Abuja, Abuja, Nigeria.
  • Gaju L; Débbo Africa, Lekki, Lagos, Nigeria.
  • Mehtar S; Federal Medical Centre Jabi, Abuja, Nigeria.
  • Bulabula ANH; National Hospital Abuja, Abuja, Nigeria.
  • Whitelaw A; Department of Microbiology, Medway Maritime Hospital NHS Foundation Trust, Gillingham, Kent, UK.
  • Roberts L; Aminu Kano Teaching Hospital, Kano, Nigeria.
  • Chan G; Aminu Kano Teaching Hospital, Kano, Nigeria.
  • Bekele D; Murtala Muhammad Specialist Hospital, Kano City, Nigeria.
  • Solomon S; Murtala Muhammad Specialist Hospital, Kano City, Nigeria.
  • Abayneh M; The National Reference Laboratory, Rwanda Biomedical Centre, Kigali, Rwanda.
  • Metaferia G; The National Reference Laboratory, Rwanda Biomedical Centre, Kigali, Rwanda.
  • Walsh TR; Unit of IPC, Stellenbosch University, Cape Town, South Africa.
Nat Commun ; 15(1): 2758, 2024 Mar 29.
Article em En | MEDLINE | ID: mdl-38553439
ABSTRACT
Hospital surfaces can harbour bacterial pathogens, which may disseminate and cause nosocomial infections, contributing towards mortality in low- and middle-income countries (LMICs). During the BARNARDS study, hospital surfaces from neonatal wards were sampled to assess the degree of environmental surface and patient care equipment colonisation by Gram-negative bacteria (GNB) carrying antibiotic resistance genes (ARGs). Here, we perform PCR screening for extended-spectrum ß-lactamases (blaCTX-M-15) and carbapenemases (blaNDM, blaOXA-48-like and blaKPC), MALDI-TOF MS identification of GNB carrying ARGs, and further analysis by whole genome sequencing of bacterial isolates. We determine presence of consistently dominant clones and their relatedness to strains causing neonatal sepsis. Higher prevalence of carbapenemases is observed in Pakistan, Bangladesh, and Ethiopia, compared to other countries, and are mostly found in surfaces near the sink drain. Klebsiella pneumoniae, Enterobacter hormaechei, Acinetobacter baumannii, Serratia marcescens and Leclercia adecarboxylata are dominant; ST15 K. pneumoniae is identified from the same ward on multiple occasions suggesting clonal persistence within the same environment, and is found to be identical to isolates causing neonatal sepsis in Pakistan over similar time periods. Our data suggests persistence of dominant clones across multiple time points, highlighting the need for assessment of Infection Prevention and Control guidelines.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Países em Desenvolvimento / Sepse Neonatal Limite: Humans / Newborn Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Países em Desenvolvimento / Sepse Neonatal Limite: Humans / Newborn Idioma: En Ano de publicação: 2024 Tipo de documento: Article